The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
暂无分享,去创建一个
[1] Y. Hashimoto,et al. Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers. , 2007, Biological & pharmaceutical bulletin.
[2] I. Tamai,et al. Identification of influx transporter for the quinolone antibacterial agent levofloxacin. , 2007, Molecular pharmaceutics.
[3] Masaki Kobayashi,et al. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. , 2006, Biochimica et biophysica acta.
[4] Y. Hashimoto,et al. Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells. , 2006, Biological & pharmaceutical bulletin.
[5] K. Inui,et al. Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels , 2006, Pflügers Archiv.
[6] M. Okuda,et al. Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2 , 2004, Pflügers Archiv.
[7] I. Yano,et al. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. , 2001, European journal of pharmacology.
[8] R. Farinotti,et al. Absorption of ofloxacin isomers in the rat small intestine , 1997, Antimicrobial agents and chemotherapy.
[9] Toshikazu Yamaguchi,et al. Intestinal Absorption Characteristics of Sparfloxacin , 1991 .